CONVENTUS BIOMEDICAL SOLUTIONS, INC.

is a privately-held consulting firm specializing in development solutions and global regulatory strategies and submissions for investigational medicinal products in early development stages through Phase 3. The Conventus team includes full-time expert personnel, and expert affiliates with deep expertise in multiple technical disciplines, who together comprise an integrated team with successful experience in a broad range of therapeutic areas and vaccine indications.

 
     
  Click here to view recent projects  
     
 
KEY PERSONNEL
 
STEVEN A. KRADJIAN, RAC
President and Principal Regulatory Consultant

ZENAIDA A. ORTEGA, MBA, CQE, CQA
Director of Quality Assurance
 
DAVID BERNAL, Pharm.D.
Director of Regulatory Affairs

PETRA PAVLICKOVA, Ph.D., RAC CQA
Associate Director of Regulatory Affairs

KURT NORTON, MS
Regulatory Associate

SERVICES OFFERED
  • Regulatory Plan and Strategy to Optimize Development Timelines
  • Regulatory Strategies for Combination Products, Biologics, Small Molecules, and Medical Devices
  • Regulatory Strategies for Biosimilars
  • Global Regulatory Submissions Management
  • Quality Assurance/Project Management
  • Pharmacology/Toxicology Planning and Oversight Through Affiliated Experts
  • CMC Biologics and Small Molecules Through Affiliated Experts
 
 
 
 
 
 

Conventus is derived from Latin convenire, meaning "to come together" which best describes our multiple consulting disciplines coming together in a single integrated development support model. Conventus also describes the relationship we like to build with our clients - coming together with a common objective.

 
 
 

Copyright@2018 Conventus BioMedical Solutions, Inc.